The Pharmaceutical Research and Manufacturers of America, PhRMA, represents the country’s leading biopharmaceutical researchers and biotechnology companies.
Since the 1990s
of 340B volume goes through DSH hospitals even though they make up just 9% of 340B entities.
The average cost to develop one new medicine.
Priority FDA review time thanks to PDUFA
have been identified to-date
Currently in development around the world.